HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis.

PubWeight™: 1.66‹?› | Rank: Top 3%

🔗 View Article (PMC 2192409)

Published in J Exp Med on January 01, 1996

Authors

G H Nabozny1, J M Baisch, S Cheng, D Cosgrove, M M Griffiths, H S Luthra, C S David

Author Affiliations

1: Department of Immunology, Mayo Medical School, Rochester, Minnesota 55905, USA.

Articles citing this

High-throughput, high-fidelity HLA genotyping with deep sequencing. Proc Natl Acad Sci U S A (2012) 2.03

HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J Exp Med (1996) 1.99

Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis. J Exp Med (1999) 1.92

An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med (1997) 1.89

HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J Exp Med (1996) 1.46

T-cell recognition of the HspX protein of Mycobacterium tuberculosis correlates with latent M. tuberculosis infection but not with M. bovis BCG vaccination. Infect Immun (2007) 1.43

Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci U S A (1998) 1.38

A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice. J Clin Invest (2003) 1.32

Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice. Proc Natl Acad Sci U S A (1998) 1.10

Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice. J Clin Invest (1998) 1.07

Human leukocyte antigen-DQ8 transgenic mice: a model to examine the toxicity of aerosolized staphylococcal enterotoxin B. Infect Immun (2005) 1.06

Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAbeta knockout NOD mice. Proc Natl Acad Sci U S A (2003) 1.04

Zinc transporter (ZnT)8(186-194) is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patients. Diabetologia (2012) 1.03

HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. J Clin Invest (1997) 1.01

Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8. Arthritis Res (2000) 0.96

Short ragweed allergen induces eosinophilic lung disease in HLA-DQ transgenic mice. J Clin Invest (1999) 0.95

HLA transgenic mice as humanized mouse models of disease and immunity. J Clin Invest (1998) 0.94

The genetics of rheumatoid arthritis and the need for animal models to find and understand the underlying genes. Arthritis Res (2000) 0.93

Association of MHC and rheumatoid arthritis. HLA-DR4 and rheumatoid arthritis: studies in mice and men. Arthritis Res (2000) 0.92

Differential responses to Smith D autoantigen by mice with HLA-DR and HLA-DQ transgenes: dominant responses by HLA-DR3 transgenic mice with diversification of autoantibodies to small nuclear ribonucleoprotein, double-stranded DNA, and nuclear antigens. J Immunol (2009) 0.91

Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice. Nat Commun (2016) 0.89

Uveitis-associated epitopes of retinal antigens are pathogenic in the humanized mouse model of uveitis and identify autoaggressive T cells. J Immunol (2011) 0.88

Identification of antigenic epitopes on human allergens: studies with HLA transgenic mice. Environ Health Perspect (2003) 0.86

To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice. J Autoimmun (2011) 0.86

Lessons from rodent models in celiac disease. Mucosal Immunol (2014) 0.85

Association of MHC and rheumatoid arthritis. Regulatory role of HLA class II molecules in animal models of RA: studies on transgenic/knockout mice. Arthritis Res (2000) 0.83

Vaccine based on a ubiquitous cysteinyl protease and streptococcal pyrogenic exotoxin A protects against Streptococcus pyogenes sepsis and toxic shock. J Immune Based Ther Vaccines (2008) 0.83

Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis. Clin Vaccine Immunol (2015) 0.83

Depletion of CD4+CD25+ regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice. Clin Exp Immunol (2007) 0.82

B cells as effectors and regulators of sex-biased arthritis. Autoimmunity (2012) 0.82

Synthetic amino acid copolymers that bind to HLA-DR proteins and inhibit type II collagen-reactive T cell clones. Proc Natl Acad Sci U S A (1998) 0.81

Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis. Gastroenterology (2008) 0.81

Nasopharyngeal infection by Streptococcus pyogenes requires superantigen-responsive Vβ-specific T cells. Proc Natl Acad Sci U S A (2017) 0.79

Mice expressing HLA-DQ6alpha8beta transgenes develop polychondritis spontaneously. Arthritis Res Ther (2006) 0.78

The challenge of early synovitis: multiple pathways to a common clinical syndrome. Arthritis Res (1999) 0.78

Superiority of thyroid peroxidase DNA over protein immunization in replicating human thyroid autoimmunity in HLA-DRB1*0301 (DR3) transgenic mice. Clin Exp Immunol (2004) 0.78

Trans heterodimer between two non-arthritis-associated HLA alleles can predispose to arthritis in humanized mice. Arthritis Rheum (2011) 0.76

Delayed onset of graft-versus-host disease in immunodeficent human leucocyte antigen-DQ8 transgenic, murine major histocompatibility complex class II-deficient mice repopulated by human peripheral blood mononuclear cells. Clin Exp Immunol (2013) 0.76

Relationship between Poor Immunogenicity of HLA-A2-Restricted Peptide Epitopes and Paucity of Naïve CD8(+) T-Cell Precursors in HLA-A2-Transgenic Mice. Immune Netw (2014) 0.75

CD74/DQA1 dimers predispose to the development of arthritis in humanized mice. Immunology (2015) 0.75

Spontaneous autoimmune myocarditis and cardiomyopathy in HLA-DQ8.NODAbo transgenic mice. J Autoimmun (2009) 0.75

Articles cited by this

The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum (1987) 14.21

HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature (1987) 10.70

Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature (1993) 8.75

Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med (1978) 7.97

Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science (1991) 7.25

Immunisation against heterologous type II collagen induces arthritis in mice. Nature (1980) 7.08

Mice lacking MHC class II molecules. Cell (1991) 6.25

Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med (1981) 5.76

Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell (1990) 4.84

Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature (1988) 4.63

Monoclonal antibody against an Ir gene product? J Exp Med (1980) 3.88

Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. J Immunol (1980) 3.39

Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med (1990) 3.05

Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J Exp Med (1985) 2.92

Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol (1988) 2.80

Molecular diversity of HLA-DR4 haplotypes. Proc Natl Acad Sci U S A (1986) 2.40

Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol (1992) 2.39

Positive selection determines T cell receptor V beta 14 gene usage by CD8+ T cells. J Exp Med (1989) 2.22

MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature (1992) 1.95

Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum (1989) 1.95

Immunogenetic control of experimental type II collagen-induced arthritis. I. Susceptibility and resistance among inbred strains of rats. Arthritis Rheum (1981) 1.79

Gene organization of DC and DX subregions of the human major histocompatibility complex. Proc Natl Acad Sci U S A (1985) 1.79

Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med (1990) 1.74

Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci U S A (1989) 1.72

Type II collagen-induced arthritis in mice. IV. Variations in immunogenetic regulation provide evidence for multiple arthritogenic epitopes on the collagen molecule. J Immunol (1985) 1.53

Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science (1986) 1.50

High antibody response to autologous type II collagen is restricted to H-2q. Immunogenetics (1986) 1.49

Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians. Further evidence for the "shared epitope" hypothesis. Arthritis Rheum (1991) 1.48

Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum (1990) 1.46

Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum (1994) 1.44

Human major histocompatibility complex class II-restricted T cell responses in transgenic mice. J Exp Med (1994) 1.40

Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol Today (1995) 1.38

Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody. Mayo Clin Proc (1984) 1.37

Transgenic HLA-DR alpha faithfully reconstitutes IE-controlled immune functions and induces cross-tolerance to E alpha in E alpha 0 mutant mice. Cell (1989) 1.37

Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. Proc Natl Acad Sci U S A (1994) 1.36

Correlation between the V beta 4+ CD8+ T-cell population and the H-2d haplotype. Immunogenetics (1990) 1.29

The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4. J Exp Med (1995) 1.23

Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity. J Exp Med (1983) 1.21

Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules. J Exp Med (1992) 1.18

Immunopathologic role of proteoglycan antigens in rheumatoid joint disease. Scand J Immunol (1980) 1.16

HLA-DQ beta-chain polymorphism linked to myasthenia gravis. Lancet (1986) 1.16

HLA-DQ beta-chain polymorphism in HLA-DR4 haplotypes associated with rheumatoid arthritis. Lancet (1987) 1.13

Conformational difference of T cell antigen receptors revealed by monoclonal antibodies to mouse V beta 5 T cell receptor for antigen determinants. J Immunol (1991) 1.01

Human leukocyte antigen-DQB1*03 alleles are associated with alopecia areata. J Invest Dermatol (1994) 1.01

Thymic deletion of V beta 11+, V beta 5+ T cells in H-2E negative, HLA-DQ beta+ single transgenic mice. J Immunol (1991) 0.99

Mechanisms of immune injury in rheumatoid arthritis: evidence for the involvement of T cells and heat-shock protein. Immunol Rev (1990) 0.97

HLA-DR4-DQw8, but not DR4-DQw7 haplotypes occur in Indian patients with rheumatoid arthritis. Rheumatol Int (1992) 0.96

Prevention of collagen induced arthritis in mice by treatment with an antibody directed against the T cell receptor alpha beta framework. Autoimmunity (1992) 0.92

Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice. J Exp Med (1994) 0.88

Human CD4-major histocompatibility complex class II (DQw6) transgenic mice in an endogenous CD4/CD8-deficient background: reconstitution of phenotype and human-restricted function. J Exp Med (1994) 0.86

Collagen-induced arthritis and TCRs in SWR and B10.Q mice expressing an Ek alpha transgene. J Immunol (1994) 0.86

HLA-DQ beta 3.1 allele is a determinant of susceptibility to DR4-associated rheumatoid arthritis. Hum Immunol (1989) 0.82

New approaches to the genetics of autoimmune disease. Concepts Immunopathol (1992) 0.78

Articles by these authors

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05

The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organization. Adv Immunol (1975) 9.19

Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. IV. Special subregion assignment of the gene(s) that codes for the suppressive T-cell factor in the H-2 histocompatibility complex. J Exp Med (1976) 6.38

Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem (1996) 5.82

Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med (1981) 5.76

Antigen-specific T-cell factor in cell cooperation. Mapping within the I region of the H-2 complex and ability to cooperate across allogeneic barriers. J Exp Med (1975) 4.64

New lymphocyte antigen system (Lna) controlled by the Ir region of the mouse H-2 complex. Proc Natl Acad Sci U S A (1973) 4.45

Genes required for cytotoxicity against virus-infected target cells in K and D regions of H-2 complex. Nature (1975) 4.41

Evidence for the expression of Ia (H-2-associated) antigens on thymus-derived lymphocytes. J Exp Med (1974) 3.56

Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med (2008) 3.49

Outmigration for coronary bypass surgery in an era of public dissemination of clinical outcomes. Circulation (1996) 3.32

The EGF-CFC protein one-eyed pinhead is essential for nodal signaling. Cell (1999) 3.15

Another view of the selective model of thymocyte selection. Cell (1993) 2.85

Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med (1986) 2.80

EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology. Ultraschall Med (2013) 2.73

T lymphocyte-enriched murine peritoneal exudate cells. III. Inhibition of antigen-induced T lymphocyte Proliferation with anti-Ia antisera. J Immunol (1976) 2.64

H-2 haplotypes, genes and antigens: second listing. II. The H-2 complex. Immunogenetics (1983) 2.62

Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc Natl Acad Sci U S A (2000) 2.49

Inhaled human insulin treatment in patients with type 2 diabetes mellitus. Ann Intern Med (2001) 2.32

Cytochrome c(2) is not essential for photosynthetic growth of Rhodopseudomonas capsulata. Proc Natl Acad Sci U S A (1986) 2.25

Lactation is associated with greater maternal bone size and bone strength later in life. Osteoporos Int (2011) 2.19

Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J Exp Med (1986) 2.18

Membrane molecules determined by the H-2 associated immune response region: isolation and some properties. Proc Natl Acad Sci U S A (1974) 2.17

Selecting SNPs in two-stage analysis of disease association data: a model-free approach. Ann Hum Genet (2000) 2.05

Serologic and genetic aspects of murine Ia antigens. Transplant Rev (1976) 2.02

Purification and properties of HuD, a neuronal RNA-binding protein. J Biol Chem (1996) 2.00

Specific amplification with PCR of a refractory segment of genomic DNA. Nucleic Acids Res (1988) 2.00

Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J Immunol (1985) 1.98

Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1. J Exp Med (1996) 1.95

A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer. N Engl J Med (1994) 1.93

Serological and functional evidence for further subdivision of the I regions of the H-2 gene complex. Cold Spring Harb Symp Quant Biol (1977) 1.91

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol (1995) 1.87

Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor. J Clin Invest (1975) 1.86

Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. Autoimmunity (1995) 1.85

Immunogenetic control of experimental type II collagen-induced arthritis. I. Susceptibility and resistance among inbred strains of rats. Arthritis Rheum (1981) 1.79

A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Br J Cancer (1989) 1.78

Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clin Sci (Lond) (2001) 1.74

Long-term acid-induced wall extension in an in-vitro system. Planta (1987) 1.73

Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med (2004) 1.68

Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ (2001) 1.67

Clinical and economic outcomes of individuals with severe peptic ulcer hemorrhage and nonbleeding visible vessel: an analysis of two prospective clinical trials. Am J Gastroenterol (1998) 1.66

International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax (2000) 1.64

Open donor, laparoscopic donor and hand assisted laparoscopic donor nephrectomy: a comparison of outcomes. J Urol (2001) 1.62

Multi-locus candidate gene polymorphisms and risk of myocardial infarction: a population-based, prospective genetic analysis. J Thromb Haemost (2006) 1.61

A genome scan localizes five non-MHC loci controlling collagen-induced arthritis in rats. Nat Genet (1996) 1.60

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

I-region-associated determinants: expression on mitogen-stimulated lymphocytes and detection by cytotoxic T cells. Eur J Immunol (1975) 1.58

Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients. Am J Transplant (2013) 1.58

Complete mitochondrial genome amplification. Nat Genet (1994) 1.58

Comparison of asthma prevalence in the ISAAC and the ECRHS. ISAAC Steering Committee and the European Community Respiratory Health Survey. International Study of Asthma and Allergies in Childhood. Eur Respir J (2000) 1.57

Inhibition of dual Ir gene-controlled T-lymphocyte proliferative response to poly (Glu56Lys35Phe9)n with anti-Ia antisera directed against products of either I-A or I-C subregion. Proc Natl Acad Sci U S A (1978) 1.55

Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens). Neurology (1986) 1.55

Possible role of V beta T cell receptor genes in susceptibility to collagen-induced arthritis in mice. J Exp Med (1988) 1.55

Type II collagen-induced arthritis in mice. IV. Variations in immunogenetic regulation provide evidence for multiple arthritogenic epitopes on the collagen molecule. J Immunol (1985) 1.53

Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen. Arthritis Rheum (1984) 1.52

Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. J Bone Miner Res (2000) 1.52

An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge. J Virol (1997) 1.50

Evidence for more than one Ia antigenic specificity on molecules determined by the I-A subregion of the mouse major histocompatibility complex. J Immunol (1976) 1.49

Regulation of granulomatous inflammation in murine schistosomiasis. In vitro characterization of T lymphocyte subsets involved in the production and suppression of migration inhibition factor. J Exp Med (1980) 1.48

HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J Exp Med (1996) 1.46

Genetic organization and evolution of the mouse H-2 region: a duplication model. Transplant Proc (1971) 1.44

Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors. Proc Natl Acad Sci U S A (2000) 1.44

Laparoscopic living donor nephrectomy: advantages of the hand-assisted method. Transplantation (1999) 1.42

A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice. Proc Natl Acad Sci U S A (2001) 1.42

Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice. Am J Physiol Gastrointest Liver Physiol (2007) 1.42

Structural predictions for the ligand-binding region of glycoprotein hormone receptors and the nature of hormone-receptor interactions. Structure (1995) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Modeling the lifetime costs of rheumatoid arthritis. J Rheumatol (1999) 1.41

Occlusive retinal vascular disease in systemic lupus erythematosus. J Rheumatol (1984) 1.41

Severe upper gastrointestinal tumor bleeding: endoscopic findings, treatment, and outcome. Endoscopy (1996) 1.40

Resolution of chronic anal fissures after treatment of contiguous internal hemorrhoids with direct current probe. Gastrointest Endosc (1997) 1.40

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

Serological and biochemical identification of hybrid Ia antigens. J Exp Med (1980) 1.38

Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol Today (1995) 1.38

Transient regional osteoporosis. A study of 56 cases and review of the literature. Ann Intern Med (1987) 1.37

Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody. Mayo Clin Proc (1984) 1.37

Serologic and biochemical studies of the Ia system of the mouse H-2 gene complex. Further evidence for I-C subregion. J Immunol (1975) 1.36

Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies. Clin Pharmacol Ther (2010) 1.36

Reconstitution of Ir genes, Ia antigens, and mixed lymphocyte reaction determinants by gene complementation. Proc Natl Acad Sci U S A (1981) 1.35

Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34

Regulation of autoimmune response to mouse thyroglobulin: influence of H-2D-end genes. J Immunol (1979) 1.34

Demonstration by MLR test of a previously unsuspected intra-H-2 crossover in the B10.HTT strain: implications concerning location of MLR determinants in the Ir region. Transplant Proc (1973) 1.33

Model collaboration between hospitals and public health system to improve tuberculosis control in China. Int J Tuberc Lung Dis (2009) 1.33

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

Bone marrow cell transplants involving intra-H-2 recombinant inbred mouse strains. Evidence that hemopoietic histocompatibility-1 (Hh-1) genes are distinct from H-2D or H-2L. J Immunol (1988) 1.32

The presence of I-region-associated antigens on B cells in molecules distinct from immunoglobulin and H-2K and H-2D. Proc Natl Acad Sci U S A (1974) 1.31

The Cox-Maze procedure: the Cleveland Clinic experience. Semin Thorac Cardiovasc Surg (2000) 1.30

A COOH-terminal peptide confers regiospecific orientation and facilitates atomic force microscopy of an IgG1. Biophys J (1993) 1.29

Isolation of the structural genes for the Rieske Fe-S protein, cytochrome b and cytochrome c1 all components of the ubiquinol: cytochrome c2 oxidoreductase complex of Rhodopseudomonas capsulata. J Mol Biol (1987) 1.29

Influence of complement C5 and V beta T cell receptor mutations on susceptibility to collagen-induced arthritis in mice. J Immunol (1989) 1.29

Identification of T-cell receptor V beta deletion mutant mouse strain AU/ssJ (H-2q) which is resistant to collagen-induced arthritis. Immunogenetics (1989) 1.28

The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale. Acta Psychiatr Scand (2000) 1.28